Stocktoria
Sana Biotechnology, Inc. SANA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-02-04
Sana Biotechnology, Inc. statistics & valuation
Market cap$951.8M
P / B5.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -58.6% | -53.2% | -50.1% | -32.8% | -31.5% |
| Return on equity | -151.8% | -106.5% | -98.5% | -54.0% | -48.9% |
| Current ratio | 1.89 | 3.54 | 3.31 | 3.99 | 5.62 |
Source: SEC EDGAR filings · CIK 0001770121 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.